Cases & Deals

Celgene files Hatch-Waxman suit against Mylan over Focalin XR® patents

Clients Celgene Corporation

Jones Day represented Celgene Corporation in a Hatch-Waxman patent infringement action against Mylan Pharmaceuticals concerning a generic version of Celgene’s branded drug Focalin XR®. This matter concluded through a settlement on mutually agreeable terms.

Celgene Corporation et al. v. Mylan Pharmaceuticals, Inc., Civil Action No. 2-11-cv-01882 (D.N.J.) (Judge Arleo)